Voyageur Pharmaceuticals Ltd. (VM.V) TSXV

0.16

+0(+0.00%)

Updated at September 05 02:13PM

Currency In CAD

Voyageur Pharmaceuticals Ltd.

Address

339–50th Avenue SE

Calgary, AB T2G 2B3

Canada

Phone

587 779 6166

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

First IPO Date

July 24, 2013

Key Executives

NameTitlePayYear Born
Mr. Brent Willis Bsc.EngPresident, Chief Executive Officer & Director132,0001971
Mr. Albert DeslauriersChief Financial Officer105,600N/A
Mr. Bradley Craig Willis P.Eng.Founder, Chief Operating Officer & Director126,0001971
Dr. Iryna Saranchova M.D., Ph.D.Chief Scientific Officer0N/A

Description

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.